Biopharm Business - BioPharm International


Biopharm Business
Insight and analysis to business aspects of biopharmaceutical development. Mergers, acquisitions, legal activities.

Global Instability Affects the Pharma Market in Brazil

April 1, 2014

How badly is Brazil's pharmaceutical market suffering from the global instability of emerging markets?

Report: Branded Biopharms Most Exposed to Biosimilar Competition

February 26, 2014

Moody's Investor Service reports AbbVie, Amgen, and Roche are the most exposed to biosimilar competition.

Lilly Acquires CGRP Antibody from Arteaus Therapeutics

January 20, 2014

Eli Lilly acquires development rights for CGRP antibody as a potential treatment for migraines.

Genmab Collaborates With Lilly On DuoBody Platform

January 20, 2014

Genmab enters collaboration with Eli Lilly to use and evaluate Genmab's DuoBody technology for bispecific antibodies.

Life-Sciences IPOs Take a Breather

January 1, 2014

Frenzy cools as investors seeking a quick return turn elsewhere.

Nearly 400 Drugs in Development for Infectious Diseases

December 16, 2013

Almost 400 new medicines for infectious diseases, including viral infections, bacterial infections, fungal infections and parasitic infections.

Employment Outlook: Mixed Results

December 1, 2013

The employment picture brightened a bit, but biopharma employees still seek better compensation.

Jobs Are Better in Biopharma, But There Is Room for Improvement

December 1, 2013

Higher wages and employment rates give biopharm professionals an edge over counterparts in other industries.

EC Approves Acquisition of Life Technologies by Thermo Fisher, With Conditions

November 26, 2013

Thermo Fisher must divest of cell culture media and sera lines, and other businesses, in purchase of Life Technologies.



Click here